Associate Director, Clinical Scientist, Hematology
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an Associate Director, Clinical Sciences to join our Hematology Oncology Clinical Sciences team, supporting our clinical programs in a matrixed, cross-functional environment. In this role, you will lead the design, execution, and scientific interpretation of hematology/oncology clinical studies across early and late phase development, while ensuring the integrity of study data. You will collaborate closely with Medical Directors and cross-functional partners, and may manage one or more clinical scientists.
Job description
When & where
- Location: Tarrytown, NY, Warren, NJ or Cambridge, MA
- Work model/flexibility: Primarily on-site with hybrid flexibility
Discover your role
- Lead or support clinical science strategy for a program, serving as Lead Clinical Scientist or delegate to the Therapeutic Area Lead
- Partner with Medical Directors to design and deliver clinical studies grounded in disease biology, the drug landscape, and current literature
- Develop the Expanded Synopsis and author or review clinical sections of protocols, amendments, and study reports
- Prepare medical monitoring plans, SAPs, and informed consents, and resolve cross-functional comments with minimal guidance
- Lead planning for and present at program team meetings, advisory boards, steering committees, DMCs, regulatory authority meetings, and investigator meetings
- Promote consistent clinical data review practices across studies, and identify risks and design mitigation strategies
- Manage and mentor clinical scientists and junior colleagues, serving as a peer coach
- Influence across functions with confidence, creativity, and professional diplomacy while driving process improvements
This role requires
- Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc) and 10+ years of pharmaceutical clinical drug development experience, including basic knowledge of oncology or hematology (other levels considered depending on experience)
- Proven leadership and accomplishment in conducting global clinical trials and executing clinical programs
- Proficient knowledge of the drug development process, Good Clinical Practice, study design, and clinical research methodology
- Solid medical writing skills
- Strong direct-line and cross-functional management, interpersonal, and problem-solving skills
Requirements
- Advanced degree in life science or healthcare (PhD, MD, PharmD, or MSc)
- 10+ years of pharmaceutical clinical drug development experience
- Basic knowledge of oncology or hematology
- Proven leadership and accomplishment in conducting global clinical trials and executing clinical programs
- Proficient knowledge of the drug development process, Good Clinical Practice, study design, and clinical research methodology
- Solid medical writing skills
- Strong direct-line and cross-functional management, interpersonal, and problem-solving skills
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension or Retirement Benefits
- 401(k) Company Match
- Health and Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.